Markets
SMCI SOUN RGTI QBTS stocks rise
Shorts! (CSA Archive/Getty Images)

Shorts get squeezed early on their tech trades

Short sellers have been getting more aggressive, but they also seem ready to bail out of trades quickly.

Top tech targets of short sellers rose sharply in early trading on Tuesday in a seemingly squeezey start to holiday-shortened trading week.

Goldman Sachs’ themed “Info Tech Most Short” basket — made up of 20 tech companies in the Russell 3000 with the highest short interest as a share of float — rose more than 2.5% in the first hour of trading.

It includes several names with massive retail interest, nosebleed valuations, and piddling profits that have attracted the attention of stock market sharks known as “the shorts.”

Those include voice AI software outfit SoundHound AI, quantum computing firms Rigetti Computing and D-Wave Quantum, and bitcoin buyer MARA Holdings.

In a research report published last week, Goldman analysts noted that hedge funds are now bolder about their short positions than they’ve been since retail traders flocked to GameStop in 2021, which dealt a blow to some sophisticated hedge funds that were shorting the stock:

“Funds increased shorts in both ETFs ($218 billion at the start of 2Q) and single stocks ($948 billion). For the first time since the 2021 short squeeze, short interest in the median S&P 500 stock ranks above the long-term historical average, rising to 2.3% of float from 1.8% in December 2024.”

But the sharp moves in the shares of heavily shorted stocks this morning — to exit trades, short sellers must buy the stock, and when many do it at once it can generate an exaggerated pop in the price — suggests some short sellers remain attuned to risks of betting against stocks with heavy interest from retail traders, and are willing to bail out fast if they see things going against them.

More Markets

See all Markets
markets

Spectrum-owner Charter Communications is on pace for its worst day ever as broadband numbers and Q1 results disappoint

Cable and broadband company Charter Communications is on pace for its worst-ever trading day on Friday, as investors dump the stock following its Q1 results and forward guidance.

Charter, which owns Spectrum, reported adjusted earnings of $9.17 per share, below Wall Street estimates of $9.96 per share from analysts polled by FactSet. On the company’s earnings call, CFO Jessica Fischer appeared to lower its full-year revenue per user guidance.

“It'll be close either way in terms of whether we end up with net growth,” said Fischer.

The company lost 120,000 internet subscribers in the quarter, deeper than the expected 94,800 and double its loss from the same period last year. That news comes one day after Comcast’s earnings provided a bit of optimism for broadband as a category: the company reported Q1 losses of 65,000, significantly improving from 183,000 losses in the same quarter last year. Comcast is down more than 10%, on pace for its worst day since January 2025.

markets

Nvidia poised to snap longest run without a record close since the AI boom began

The stock price of the company responsible for the brains of the AI boom is finally showing some brawn again.

Nvidia, the world’s most valuable company, is poised to close at a record high for the first time since October 29, 2025, on Friday (if it ends above $207.04).

The AI chip trade is on fire, with the Philadelphia Semiconductor Index slated to deliver its 18th consecutive gain as Intel’s robust results and outlook juice the entire ecosystem. Hyperscalers report earnings next week, and their capex guidance can be thought of as the earnings guidance for Nvidia and other AI suppliers for the quarters to come.

This would end Nvidia’s longest stretch without a record close since the unofficial start of the AI boom (when the chip designer delivered blowout quarterly results in May 2023).

(Sorry if I jinx this!)

markets

Lilly slips after prescriptions for its weight-loss pill come in below expectations in second week

Eli Lilly fell on Friday after prescription data for its new weight-loss pill, Foundayo, showed that it’s having a significantly slower rollout than its top competitor.

The pill was prescribed about 3,700 times in its second week, according to IQVIA data cited by Deutsche Bank analysts, compared to the roughly 8,000 they were expecting. Novo Nordisk’s Wegovy pill, which came out in January, hit over 18,000 prescriptions in its second week.

The FDA approved Foundayo on April 1 and shipments began on April 9. Deutsche analysts noted that Lilly’s GLP-1 injections, which currently outsell Novo’s, also had a slower start.

Lilly fell more than 4% after the numbers were released. Novo Nordisk rose more than 5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.